Literature DB >> 28661051

N-linked glycosylation of a subunit isoforms is critical for vertebrate vacuolar H+ -ATPase (V-ATPase) biosynthesis.

Sally Esmail1, Norbert Kartner1, Yeqi Yao1, Joo Wan Kim1, Reinhart A F Reithmeier2, Morris F Manolson1,2.   

Abstract

The a subunit of the V0 membrane-integrated sector of human V-ATPase has four isoforms, a1-a4, with diverse and crucial functions in health and disease. They are encoded by four conserved paralogous genes, and their vertebrate orthologs have positionally conserved N-glycosylation sequons within the second extracellular loop, EL2, of the a subunit membrane domain. Previously, we have shown directly that the predicted sequon for the a4 isoform is indeed N-glycosylated. Here we extend our investigation to the other isoforms by transiently transfecting HEK 293 cells to express cDNA constructs of epitope-tagged human a1-a3 subunits, with or without mutations that convert Asn to Gln at putative N-glycosylation sites. Expression and N-glycosylation were characterized by immunoblotting and mobility shifts after enzymatic deglycosylation, and intracellular localization was determined using immunofluorescence microscopy. All unglycosylated mutants, where predicted N-glycosylation sites had been eliminated by sequon mutagenesis, showed increased relative mobility on immunoblots, identical to what was seen for wild-type a subunits after enzymatic deglycosylation. Cycloheximide-chase experiments showed that unglycosylated subunits were turned over at a higher rate than N-glycosylated forms by degradation in the proteasomal pathway. Immunofluorescence colocalization analysis showed that unglycosylated a subunits were retained in the ER, and co-immunoprecipitation studies showed that they were unable to associate with the V-ATPase assembly chaperone, VMA21. Taken together with our previous a4 subunit studies, these observations show that N-glycosylation is crucial in all four human V-ATPase a subunit isoforms for protein stability and ultimately for functional incorporation into V-ATPase complexes.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ATPase; ER-associated degradation; N-glycosylation; membrane protein; protein degradation; proton pump; trafficking

Mesh:

Substances:

Year:  2017        PMID: 28661051     DOI: 10.1002/jcb.26250

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Molecular mechanisms of cutis laxa- and distal renal tubular acidosis-causing mutations in V-ATPase a subunits, ATP6V0A2 and ATP6V0A4.

Authors:  Sally Esmail; Norbert Kartner; Yeqi Yao; Joo Wan Kim; Reinhart A F Reithmeier; Morris F Manolson
Journal:  J Biol Chem       Date:  2018-01-08       Impact factor: 5.157

2.  Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.

Authors:  Longfei Wang; Di Wu; Carol V Robinson; Hao Wu; Tian-Min Fu
Journal:  Mol Cell       Date:  2020-10-15       Impact factor: 17.970

Review 3.  Sugary Logistics Gone Wrong: Membrane Trafficking and Congenital Disorders of Glycosylation.

Authors:  Peter T A Linders; Ella Peters; Martin Ter Beest; Dirk J Lefeber; Geert van den Bogaart
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 4.  V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis.

Authors:  Xiaohong Duan; Shaoqing Yang; Lei Zhang; Tielin Yang
Journal:  Theranostics       Date:  2018-10-26       Impact factor: 11.556

5.  Cryo-EM and MD infer water-mediated proton transport and autoinhibition mechanisms of Vo complex.

Authors:  Soung-Hun Roh; Mrinal Shekhar; Grigore Pintilie; Christophe Chipot; Stephan Wilkens; Abhishek Singharoy; Wah Chiu
Journal:  Sci Adv       Date:  2020-10-07       Impact factor: 14.136

6.  Mutations in the V-ATPase Assembly Factor VMA21 Cause a Congenital Disorder of Glycosylation With Autophagic Liver Disease.

Authors:  Magda Cannata Serio; Laurie A Graham; Angel Ashikov; Tom H Stevens; Matias Simons; Dirk J Lefeber; Lars Elmann Larsen; Kimiyo Raymond; Sharita Timal; Gwenn Le Meur; Margret Ryan; Elzbieta Czarnowska; Jos C Jansen; Miao He; Can Ficicioglu; Pavel Pichurin; Linda Hasadsri; Berge Minassian; Alessandra Rugierri; Hannu Kalimo; W Alfredo Ríos-Ocampo; Christian Gilissen; Richard Rodenburg; Johan W Jonker; Adriaan G Holleboom; Eva Morava; Joris A Veltman; Piotr Socha
Journal:  Hepatology       Date:  2020-12       Impact factor: 17.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.